Medical devices behemoth Stryker agreed to buy Inari Medical for $4.9 billion. Inari stock catapulted Tuesday on the news.

Stryker's acquisition of Inari for $4.9B enhances its neurovascular portfolio and boosts revenue growth by 50bp, with minimal ...

Stryker said it has a definitive agreement to purchase Inari Medical for $80 per share, a big premium that values the deal at ...

Medical-device maker Stryker on Monday agreed to acquire Inari Medical , which makes devices that treat patients with venous ...

But Stryker's stock dipped over 2%, as Wall Street wrestled with the $80-per-share valuation and questions about short-term ...

Inari Medical, Inc. NARI is well-poised for growth on the back of a huge market opportunity for its products and its ...

Shares of Inari Medical, Inc. (NASDAQ:NARI – Get Free Report) have received an average rating of “Moderate Buy” from the ...

Stay informed and make data-driven decisions with our Ratings Table. Inari Medical Inc is a medical device company focused on developing products to treat patients suffering from Chronic Venous ...

On the heels of rumors that have swirled over the past month, Stryker Corporation has officially announced a $4.9 billion acquisition of Inari Medical. The deal includes a tender offer for all ...

Inari Medical, Inc. NARI is well-poised for growth on the back of a huge market opportunity for its products and its commitment to understanding the venous system. However, the company’s ...